retatrutide ly3437943 glp-1 gip glucagon receptor agonist Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic Polypeptide, and Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature Retatrutide vs Tirzepatide (2026): Differences
Description
J Mol Med 86:516
Over the following year, his liver enzymes remained mildly elevated but stable, prompting no further evaluation
Weight cycling, a scenario likely in real-world GLP-1 therapy use due to treatment discontinuation and subsequent weight regain, further increases this risk, as repeated cycles of weight loss and regain are associated with cumulative muscle loss and progressive declines strength [25]
Key difference: Oral semaglutide tablets are generally more stable than injectable forms because they do not rely on the same protein-in-solution structure
